Abstract

In the majority of cases, acute pancreatitis is a short-lived illness with rapid resolution of symptoms, signs and biochemical abnormalities. Nevertheless, there is evidence that even after relatively mild attacks of acute pancreatitis, disturbances of exocrine function may persist for several months (Mitchell et al. 1979). Some patients suffer recurrent attacks of mild acute pancreatitis, recurrent pain being particularly likely to occur on the resumption of normal eating during convalescence from an attack. One of the principles of therapeutics is to rest the organ that is diseased, and this is applied to the management of acute pancreatitis by the withdrawal of food and the institution of nasogastric aspiration to minimise stimuli which result in the secretion of pancreatic juice. We reasoned that it might help to extend the period of pancreatic rest into the convalescent phase of the attack in the hope that it could lead to more rapid recovery of exocrine function and that it might prevent recurrent attacks of pancreatitis when eating recommenced. Accordingly, we carried out a randomised placebo-controlled trial of granular pancreatin (Creon) during the convalescent stage of acute pancreatitis, in order to investigate its influence upon exocrine function, endocrine function and abdominal pain.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.